Frank Morich - Mar 3, 2025 Form 4 Insider Report for Perspective Therapeutics, Inc. (CATX)

Role
Director
Signature
/s/ Frank Morich by Chris Nenno, as Attorney-in-Fact
Stock symbol
CATX
Transactions as of
Mar 3, 2025
Transactions value $
$0
Form type
4
Date filed
3/5/2025, 04:20 PM
Previous filing
Jan 3, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CATX Stock option (right to buy) Award $0 +50K $0.00 50K Mar 3, 2025 Common Stock 50K $2.46 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option grant was approved by the Issuer's Board of Directors on February 12, 2025, with a grant date of March 3, 2025, and represents the Reporting Person's annual equity award for 2025.
F2 Option vests in full on March 3, 2026, subject to the Reporting Person's continued service on the vesting date.

Remarks:

Exhibit 24